MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

opportunistic salpingectomy

Search medical newsFind research, conditions and clinical updates
  • Home
  • opportunistic salpingectomy
A Proactive Approach to Ovarian Cancer: The New ESGO Consensus on Opportunistic Salpingectomy
Posted innews Oncology

A Proactive Approach to Ovarian Cancer: The New ESGO Consensus on Opportunistic Salpingectomy

Posted by By MedXY 02/09/2026
The European Society of Gynaecological Oncology (ESGO) has released new consensus statements advocating for opportunistic salpingectomy—removing fallopian tubes during unrelated surgeries—to significantly reduce ovarian cancer risk without compromising hormone health.
Read More
Influence of Physician Peer Networks on the Adoption of Opportunistic Salpingectomy for Ovarian Cancer Prevention
Posted inClinical Updates OB/GYN & Women's Health

Influence of Physician Peer Networks on the Adoption of Opportunistic Salpingectomy for Ovarian Cancer Prevention

Posted by By MedXY 09/23/2025
Physician peer influence significantly increases the adoption of opportunistic salpingectomy during postpartum and interval tubal sterilizations, enhancing ovarian cancer prevention.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Enhanced Palatal Donor-Site Healing with Chitosan and Injectable PRF: Insights from a Randomized Clinical Trial
  • Evaluating Prone Positioning and High-Frequency Oscillatory Ventilation in Pediatric ARDS: Insights from the PROSpect Trial
  • Impact of Caregiver Mental Health on the Efficacy of Parenting Interventions in Rural China
  • Optimizing Referral Triage to Identify Inflammatory Rheumatic and Musculoskeletal Diseases: Validation and Implications
  • Inpatient Mobility Scores Predict Liver Transplant Outcomes and Mortality in Hospitalized Cirrhosis Patients
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top